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Purpose: Failure of the adrenocortical system after open repair of ruptured abdominal aortic aneurysm (RAAA) has never
been reported, to our knowledge. This study was undertaken to examine the incidence and response to treatment of
adrenal insufficiency in the RAAA population.
Methods: A 6-year retrospective analysis was carried out on data for all patients admitted after RAAA repair. A cosyntropin
stimulation test (CST) was performed in patients with unexplained postoperative hypotension. Patients with adrenal
insufficiency were given stress dose hydrocortisone, followed by slow hydrocortisone taper.
Results: Twenty of 26 patients admitted after RAAA repair survived longer than 1 week. Nine of these 20 patients
underwent CST because of unexplained hypotension, and six patients were found to have adrenal insufficiency.
Compared with the three patients with normal CST and the 11 patients with normotension who did not require testing,
patients with adrenal insufficiency had greater preoperative hypotension (83% vs 29%; P  .05), greater operative blood
loss (7.0  1.6 L vs 3.0  0.9 L; P  .003), longer lower extremity ischemia time (5.0  2.3 hours vs 1.3  0.5 hours;
P .025), and lower intraoperative urine output (0.8 0.4 mL/kg/hr vs 2.1 0.6 mL/kg/hr; P .023). No difference
in length of stay (40  18 days vs 35  26 days), major complications (27% vs 32%), or overall mortality (17% vs 15%)
was demonstrated with steroid therapy. Initiation of steroid therapy enabled weaning of vasopressor support within 48
hours in patients with adrenal insufficiency.
Conclusions: Adrenal insufficiency was identified in 67% of patients with RAAA with unexplained postoperative
hypotension given a CST. Predictors of adrenal insufficiency after RAAA repair include preoperative hypotension and a
complicated operative course. Steroid therapy can limit vasopressor dependence, and is not associated with increased
morbidity or mortality. (J Vasc Surg 2004;39:944-50.)It is well established that severe illness and stress acti-
vate the hypothalamic-pituitary-adrenal (HPA) axia, result-
ing in the release of cortisol from the adrenal cortex. In
critically ill patients the highest cortisol levels are found in
those with the highest illness-severity scores, and such
levels are an independent predictor of survival.1-3 Specifi-
cally, some patients manifest a response on the order of five
to 10 times the normal stress response, which may signal
such significant injury in these patients that despite an
aggressive sympathetic response survival is limited. Braams
et al4 corroborated this finding in patients with ruptured
abdominal aortic aneurysms (RAAA), noting that exceed-
ingly high cortisol levels are associated with death. To our
knowledge, failure of the HPA axis and hypocortisolism in
this specific population has not been previously reported.
A review of the recent critical care literature reveals that
the overall incidence of adrenal insufficiency in critically ill
patients approximates 30%, increasing to as high as 50% to
60% in the subset with septic shock.3,5,6 Adrenal insuffi-
ciency is occult in most of these patients, with hemody-
namic instability as its only manifestation. This occult, or
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septic shock leading to vasopressor dependence and death
from multisystem organ dysfunction.7,8 Physiologic steroid
replacement therapy improves hemodynamics, limits vaso-
pressor dependence, and increases survival in these pa-
tients.9-11 The present study was undertaken to identify the
incidence of adrenal insufficiency in patients undergoing
open repair of RAAA and to determine the response to
steroid replacement therapy in this population.
METHODS
The study was conducted at Henry Ford Hospital, a
large urban tertiary care referral center serving southeastern
Michigan. A retrospective analysis was performed to iden-
tify all patients who underwent open repair of RAAAs from
January 1996 to April 2002. Patients were identified from
our computerized vascular surgery registry and operative case
logs. Excluded from study were patients with aortic aneurysms
not abdominal in origin and those with a history of adrenal-
ectomy, adrenal insufficiency, or steroid dependence. Study
patient medical records were abstracted for demographic
data, hospital course (including resuscitation, course of
vasopressor therapy, and response to steroid therapy if used),
postoperative complications, survival, and disposition.
Postoperatively all patients were admitted to a surgical
intensive care unit, where resuscitation was continued.
Anemia (hemoglobin 8) and coagulopathy were cor-
rected with blood product replacement as needed. All
patients received intravenous crystalloid fluids at a rate of
one and a half times maintenance. The remaining fluid
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col. Specifically, 500-mL lactated Ringer fluid boluses were
administered over 5 minutes for a mean arterial pressure
(MAP) less than 65 mm Hg, serum lactate greater than 2.0
mmol/L, or urine output less than 0.5 mL/kg/hr. Sys-
temic arterial blood pressure, heart rate, central venous
pressure, and cardiac output were recorded before fluid
challenge and at 5 and 10 minutes after fluid challenge. A
20% or greater increase in cardiac output was considered
evidence of hypovolemia. An increase of less than 20%
indicated normovolemia, and a decrease of greater than
20% indicated hypervolemia. After demonstrated normo-
volemia, continued hypotension (MAP 65 mm Hg) was
treated with administration of vasopressor agents, most
commonly dopamine at 6 to 30 g/kg/min or epineph-
rine at 2 to 100 g/min.
Patients with persistent hemodynamic instability after
adequate volume resuscitation were studied with the short
cosyntropin stimulation test (CST; Cortrosyn; Organon
Pharmaceuticals, West Orange, NJ). During the normal
stress repsonse the hypothalamus releases corticotropin
releasing hormone, which in turn stimulates the anterior
pituitary to secrete adrenocorticotrophic hormone
(ACTH). ACTH then leads to direct stimulation of the
adrenal cortex to produce cortisol. Cosyntropin, a synthetic
peptide consisting of the first 24 amino acids of corticotro-
phin, is an ACTH analog, and when administered has the
same stimulatory effects on the adrenal cortex. During the
CST, after collection of a baseline serum cortisol level, 250
g of cosyntropin was administered by intravenous bolus.
Serum cortisol levels were then determined with standard
chemiluminescent assay kits in the chemistry laboratory at
30 and 60 minutes post-stimulation.
Patients with a baseline serum cortisol concentration
less than 15g/dL were defined as having adrenal dysfunc-
tion.3,8,12,13 Patients with a cortisol concentration between
15 and 34g/dL and a minimal response to cosyntropin (a
change in cortisol concentration of 9 g/dL or less) were
defined as having functional hypoadrenalism or ACTH
resistance.1,10,12-16 Patients with a baseline cortisol con-
centration greater than 34 g/dL were judged to have
normal adrenal function. Adrenal insufficiency was defined
as the presence of either adrenal dysfunction or functional
hypoadrenalism. Patients determined to have adrenal insuf-
ficiency received steroid therapy with intravenous hydro-
cortisone acetate (100 mg every 8 hours for three doses),
followed by a slow taper over 2 to 3 weeks.
Data were statistically analyzed with the Pearson 2 test
for categorical variables and the Student two-sample t test
for continuous variables. Analysis of complications, risk
factors, and operative and resuscitation factors was per-
formed with an unpaired t test and the Fisher exact test. All
data are expressed as mean SD. Statistical significance was
assigned at P  .05.
RESULTS
During the study 31 patients were operated on to treat
RAAA, including 24 (77%) patients with evidence of activebleeding and hemodynamic instability, and seven (23%)
patients with evidence of recent hemorrhage on CT scans
but no active extravasation of contrast medium. Their mean
age was 72.8 11.5 years, with a male-female ratio of 23:8.
Five patients (16%) who died during the operation and
another six patients (19%) who died within the first 36
hours after the operation were excluded from the study.
The remaining 20 (65%) patients survived more than 1
week postoperatively, and constitute our study population.
Nine of these 20 patients underwent CST, because of
persistent hemodynamic instability and the need for vaso-
pressor support. Six (67%) of these nine patients had adre-
nal insufficiency; specifically, one of the six patients had
adrenal dysfunction, and the remaining five patients had
functional hypoadrenalism (Table I). All six of these pa-
tients (adrenal insufficiency group) received steroid re-
placement therapy for a mean of 13  5 days, and the
remaining 14 patients (non–adrenal insufficiency group)
received no steroid treatment. In the patients with adrenal
insufficiency requiring vasopressor therapy pharmacologic
support was weaned at a mean interval of 35 9 hours after
initiation of steroid therapy (Fig).
In comparison of the groups with and without adrenal
insufficiency, there were no significant differences in age
(69  9 years vs 72  11 years), male-female ratio (83%:
17% vs 79%:21%), or infrarenal versus juxtarenal origin of
RAAA (67%:33% vs 71%:29%). There were also no differ-
ences in serum electrolyte, glucose, or creatinine concen-
trations between the two groups, either preoperatively or in
the immediate postoperative period. At 24 hours postop-
erative, heart rate, central venous pressure, pulmonary cap-
illary wedge pressure, and cardiac index were similar be-
tween the two groups, indicating that both groups had
undergone adequate volume resuscitation and achieved an
equivalent state of normovolemia. There was, however, a
significant difference in MAP, systemic vascular resistance,
and amount of fluids required to achieve normovolemia;
the adrenal insufficiency group had lower MAP and sys-
temic vascular resistance, and received more crystalloid
fluid in the first 24 hours, compared with the non– adrenal
insufficiency group (Table II). In addition, 67% of the
adrenal insufficiency group required treatment with vaso-
Table I. Results of cosyntropin stimulation test
Patient
Baseline
Cortisol
(g/dL)
30 Minutes
post-
stimulation
(g/dL)
60 Minutes
post-
stimulation
(g/dL) Definition
1 3.4 14.0 13.5 AD
2 17.3 22.8 25.4 FH
3 17.5 21.7 23.3 FH
4 18.4 22.2 26.7 FH
5 21.9 24.6 27.5 FH
6 23.2 25.5 27.8 FH
7 20.4 45.1 51.9 Normal
8 24.2 36.9 42.8 Normal
9 33.1 58.6 58.1 Normal
AD, Adrenal dysfunction; FH, functional hypoadrenalism.
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pared with only 33% of the non– adrenal insufficiency group.
Review of the operative courses in the two groups also
revealed significant differences. The adrenal insufficiency
group had a higher incidence of preoperative hypotension
(MAP, 65 mm Hg), greater operative blood loss, longer
total lower extremity ischemic time, and lower intraopera-
tive urine output (Table III). There was, however, no
difference in the duration of supraceliac aortic cross-clamp-
ing between the two groups.
Outcomes in the two groups were also compared (Ta-
ble IV). Mortality in both groups was similar, approxi-
mately 15%. Major complication rates were also similar. No
differences in intensive care unit or hospital length of stay
were identified. However, none of the patients with adrenal
insufficiency were discharged directly to home; all five
survivors were transferred to an extended care facility for
further convalescence. In comparison, three of nine (29%)
surviving patients without adrenal insufficiency were dis-
charged to home to resume their preadmission lifestyle.
DISCUSSION
Cortisol is the predominant glucocorticoid secreted by
the adrenal cortex, and is under the direct control of the
Timeline for improvement of v
Table II. Hemodynamic data 24 hours postoperative
AI group
(n  6)
Non-AI group
(n  14) P
Temperature (°C) 36.4  0.8 37.1  0.6 .08
Heart rate 93  12.3 98  18.6 .10
MAP (mm Hg) 51  11.6 74  13.9 .04
Crystalloid resuscitation (L) 8.2  2.1 4.5  1.9 .004
CVP (mm Hg) 12.8  4.4 14.1  3.6 .10
PCWP (mm Hg) 15.1  5.1 17.3  4.1 .11
Cardiac index (L/min/m2) 2.9  1.2 3.3  0.8 .21
SVR (dynes/s/cm5) 529  136 935  256 .02
AI, Adrenal insufficiency; MAP, mean arterial pressure; CVP, central venous
pressure; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascu-
lar resistance.HPA axis. Activation of this system is crucial in responding
to stress and illness and in maintaining normal cellular and
organ homeostasis. Typically, the stress of severe illness,
trauma, and major surgery results in a twofold to 10-fold
increase in cortisol secretion, and loss of the normal diurnal
secretory pattern.6 Failure to achieve this upregulation in
cortisol synthesis leads to a state of adrenal insufficiency,
which has been recognized as a significant contributor to
morbidity and mortality in as many as 30% of critically ill or
injured patients with either systemic inflammatory response
syndrome or sepsis.5,6
The level of circulating cortisol considered an adequate
response to stress remains controversial. In healthy ambu-
latory subjects hypoglycemic stress is induced by adminis-
tration of insulin; severe hypoglycemia (glucose concentra-
tion, 30 mg/dL) usually increases cortisol levels to
greater than 25 g/dL.17 Critical illness, pain, fever, hypo-
tension, and tissue damage usually result in a sustained
increase in cortisol secretion, with loss of the normal diur-
nal variation. Several studies have demonstrated that an
adequate stress response in a critically ill patient is associ-
ated with a serum cortisol level greater than 34 g/dL, and
a level less than 15 to 25 g/dL is consistent with a state of
adrenal insufficiency.3,10,11,17-19 Even an adequate cortisol
essor-dependent hypotension.
Table III. Operative data
AI group
(n  6)
Non-AI group
(n  14) P
OR time (hr) 6.9  3.8 2.7  1.0 .003
Preoperative MAP 65 mm Hg 5 (83%) 4 (28%) .05
Estimated blood loss (L) 7.0  1.6 3.0  0.9 .003
Blood products (L) 10.5  3.3 3.5  1.7 .001
Crystalloid (L) 6.2  1.2 3.5  1.9 .004
Urine output (mL/kg/hr) 0.8  0.4 2.1  0.6 .023
Supraceliac clamp time (min) 20  11 19  14 .230
Total ischemia time (hr)* 5.0  2.3 1.3  0.5 .025
AI, Adrenal insufficiency; OR, operating room; MAP, mean arterial pres-
sure.
*Total time to restore perfusion to both lower extremities.asopr
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state of functional hypocortisolism, because a systemic in-
flammatory state can result in a decrease in glucocorticoid
receptor binding affinity for cortisol.18 This effect is com-
pounded in patients who are unable to mount the normal
physiologic stress response, such that their modest levels of
cortisol are essentially ineffective, and extended physiologic
doses of corticosteroids are needed to overcome this abnor-
mality.
The use of the CST is also controversial. Some author-
ities believe that the CST is a measure of adrenal reserve
rather than adrenal function, reasoning that a maximally
stressed patient may be secreting all the cortisol his or her
adrenal glands can synthesize. Other investigators have
pointed out that exogenous corticotropin administration
bypasses the central nervous system portion of the HPA axis
and addresses only the integrity of the adrenal gland it-
self.5,6 Nevertheless, a substantial body of evidence dem-
onstrates that a minimal change in cortisol levels after CST
(an increase or delta cortisol 9 g/dL above baseline 60
minutes post-stimulation) is associated with increased mor-
tality.1,10,12,14 Patients with such blunted response are
believed to have either functional hypoadrenalism or
ACTH resistance, and are thought to be candidates for
supplemental corticosteroid therapy.1,11,14
Hemodynamic instability is one of the hallmarks of
classic adrenal insufficiency. Twenty-four hours after AAA
repair the adrenal insufficiency group required significantly
more fluid resuscitation to achieve normovolemia than did
the non–adrenal insufficiency group. In addition, 67% of
patients with adrenal insufficiency required intravenous
vasopressor support to maintain MAP greater than 65 mm
Hg, compared with only 33% of patients without adrenal
insufficiency. It is well recognized that glucocorticoids are
required for normal cardiovascular reactivity to both cat-
echolamines and angiotensin II. Not only do glucocorti-
coids increase the synthesis of catecholamines, they also
upregulate the transcription and expression of -adrenergic
and -adrenergic receptors for these hormones, and de-
crease the production of nitric oxide, a potent vasodilator
and modulator of vascular permeability.19,20 The net ef-
fects of these functions is maintenance of normal cardiac
contractility, vasomotor tone, and blood pressure. Low
levels of cortisol would hence be expected to lead to vaso-
motor dysfunction and hypotension, which should be re-
versed by correcting the cortisol deficiency. Our data cor-
roborate the results of several other larger studies that
showed that low-dose corticosteroid therapy improves he-
modynamics, accelerates shock reversal, and decreases va-
sopressor dependence in some critically ill adults.9-11,21
Although most of these reports focused on patients with
sepsis, the general principles remain valid, mindful that all
of our patients with adrenal insufficiency had refractory
hypotension, catecholamine dependence, and vasomotor
instability, a pattern seen in many patients with sepsis.
Other classic manifestations of adrenal insufficiency
include hyponatremia, hyperkalemia, hypercalcemia, hypo-
glycemia, metabolic acidosis, and eosinophilia.12,14 Thesefindings relate to deficiencies in both glucocorticoid and
mineralocorticoid function. Typical electrolyte abnormali-
ties, however, were not present in our patients. This may
have resulted from early detection of adrenal insufficiency,
before electrolyte changes started. Alternatively, such
changes may have been masked by the significant perioper-
ative fluid resuscitation these patients received. Similarly,
acidosis was aggressively treated in all patients, which lim-
ited our ability to detect subtle differences between the two
groups. We did not evaluate our patients for the presence of
eosiniphilia, because our complete blood cell counts do not
routinely include a white blood cell differential analysis.
Nevertheless, several studies have shown that eosinophilia
is relatively uncommon in critically ill patients and should
alert the physician to the possible presence of adrenal
insufficiency.22
The 30% overall incidence of adrenal insufficiency in
our study parallels that in the literature for patients with
other critical illnesses. Inasmuch as only nine patients un-
derwent testing, and six were found to have adrenal insuf-
ficiency, the true incidence of adrenal insufficiency in pa-
tients with RAAA may have been underestimated. There
are several reasons why adrenal insufficiency may be com-
mon in patients with RAAA. First, the massive systemic
inflammatory response mounted by these acutely ill pa-
tients leads to release of inflammatory cytokines, which
downregulate the HPA axis or directly inhibit adrenal
cortisol synthesis.23 Specifically, elevations in interleukin-6
or tumor necrosis factor- impair hypothalamic release of
ACTH, and several studies have noted inappropriately low
levels of ACTH in patients with sepsis and systemic inflam-
matory response syndrome.24,25 A second potential cause
of adrenal insufficiency in patients with RAAA is direct
injury to the adrenal glands from either ischemia or hem-
orrhage. The higher incidence of preoperative hypotension
(MAP, 65 mm Hg), greater operative blood loss, and
lower intraoperative urine output found in the adrenal
Table IV. Outcome
AI group
(n  6)
Non-AI
group
(n  14)
Pn % n %
Bowel ischemia 1 17 3 21 1.0
Respiratory failure* 3 50 8 57 .63
Myocardial infarction 1 17 3 21 1.0
Acute renal failure† 2 33 5 35 1.0
Wound problems 1 17 3 21 1.0
Sepsis‡ 3 50 8 57 .20
Death 1 17 2 14 .21
Discharge status
Home 0 0 4 29 .04
Extended care 5 83 8 57
AI, adrenal insufficiency.
*Defined as 72 hours on ventilator.
†Defined as need for hemodialysis.
‡Defined as positive blood cultures.
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perfusion. Hypoperfusion can be compounded by tempo-
rary interruption of critical adrenal blood supply during
supraceliac aortic cross-clamping. The absence of a demon-
strable effect with supraceliac clamping may be due to the
relatively short supraceliac aortic occlusion times in this
study (mean, 33.1  11.7 minutes) and the triple blood
supply of the adrenal gland. When the aortic and renal
blood supply is reduced, phrenic collateral arterial branches
may be sufficient to preserve function. Microvascular
thrombosis is another well-recognized complication of
RAAA surgery, and can also lead to end-organ ischemia.26
Adrenal hemorrhage and subsequent gland dysfunction can
result from the coagulopathy frequently found with RAAA.
A final contributing factor to the incidence of adrenal
insufficiency in this study may have been the age of our
patients (mean, 72  11 years). Previous work by Barquist
and Kirton13 established that critically ill adults older than
55 years are at threefold increased risk for adrenal insuffi-
ciency, compared with younger patients.
The benefits of corticosteroid therapy in patients with
critical illness and sepsis have been extensively debated in
the literature for more than three decades.27-31 A large
number of randomized, well-designed, multicenter trials
have revealed that there is no benefit, and perhaps harm,
associated with short-duration high-dose steroid adminis-
tration to treat septic shock.32-34 An unintended outcome
of these studies, however, has been the identification of a
subset of patients with relative adrenal insufficiency who do
benefit from physiologic steroid replacement. It must be
recognized that patients who undergo RAAA repair are
clinically different from those with septic shock. Despite
physiologic parameters that may mimic shock, these pa-
tients have neither immunocompromise nor sepsis in the
initial postoperative period. However, it is also important
to realize that the benefits of steroid replacement to treat
adrenal insufficiency in these patients should mimic those in
other critically ill patients with similar hypoadrenalism.
The widespread avoidance of steroid therapy in surgical
patients is the result of surgeon concerns about possible
impaired wound healing and immunosuppression leading
to secondary infections. In the current analysis we found no
increase in the incidence of major complications or mortal-
ity in the steroid-treated group. Problems with wound
healing and infections are probably of more concern when
suprapharmacologic doses of corticosteroids are advocated.
The management strategy today involves administering
physiologic doses of corticosteroids to correct the relative
adrenal insufficiency, without untoward immunosuppres-
sion.7,10,11,18 The only outcome measure that differed
between the steroid-treated and untreated groups in this
study was that patients with adrenal insufficiency took
longer to return to their prehospital lifestyles than did
patients without adrenal insufficiency, despite equivalent
intensive care unit and hospital length of stay. The reasons
for this difference are unclear, and may be associated with
adrenal insufficiency inferring a sicker population that is lesslikely to be able to return home. Our study group is not
large enough to support any firm conclusions.
The limitations of this study are evident. Since testing
for adrenal insufficiency was selective, it is unclear what the
true incidence of this syndrome is in patients with RAAA.
The small size of our subgroup analysis limited the statisti-
cal power of the study. In addition, this study does not truly
examine the effect of adrenal insufficiency on morbidity and
mortality in patients with RAAA. We noted that patients
given steroid therapy had equivalent mortality as those
without treatment, but there was no control group of
patients with adrenal insufficiency who received no ste-
roids, to clearly analyze this point. In addition, since no
autopsies were performed in the patients who died, we
cannot correlate our biochemical findings with pathologic
changes in the adrenal glands. Finally, there is some con-
troversy about the use of high-dose CST (250 g of
cosyntropin), because this may represent supraphysiologic
stimulation and yield false positive results. To date, low-
dose CST (1 g of cosyntropin) is still under study, and a
multicenter randomized trial is needed before this is ac-
cepted as the test of choice.
CONCLUSIONS
The response of the HPA axis to stress is the liberation
of cortisol from the adrenal cortex; it is an essential com-
ponent in patient adaptation to stress and illness and con-
tributes to the maintenance of cellular and organ ho-
meostasis. Even minor degrees of adrenal insufficiency
increase mortality in critically ill or injured patients, yet
recognition of this entity remains challenging. Important
diagnostic clues include hemodynamic instability despite
adequate fluid resuscitation, and ongoing inflammation or
systemic inflammatory response syndrome without an ob-
vious source. This study suggests that adrenal insufficiency
is a common complication of RAAA repair. Identified risk
factors for development of adrenal insufficiency include
preoperative hypotension, complicated operative course,
prolonged lower extremity ischemia, and need for vasopres-
sors despite a normovolemic or hypervolemic response to
fluid challenge. Inasmuch as the classic biochemical fea-
tures of adrenal insufficiency are not usually present, a high
index of suspicion for this diagnosis is needed in this
population. Hydrocortisone replacement therapy permits
rapid weaning of vasopressors in patients with adrenal
insufficiency requiring such support, and is not associated
with any increase in morbidity or mortality.
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Available online Mar 8, 2004.DISCUSSIONDr Gilbert Upchurch (Ann Arbor, Mich). A couple of years
ago, with the help of the psychiatrist Linda Graham, when she was
at Michigan, we started looking at the role of the endocrine system
in patients undergoing aortic surgery. Most of the interesting
findings occurred in the elective setting. Subsequently that is the
group that we have studied further. We have tried to sort out if low
cortisol levels preoperatively dictate poor outcomes. My question
is that you are only talking about seven patients in the present
study. Have you considered doing this in your elective AAA
patients, which obviously is a larger population? My second ques-
tion would be, How would you would predict that open repair
versus endovascular repair might affect cortisol levels?
Dr Manesh Parikshak. We have considered testing for adre-
nal insufficiency in our patients undergoing elective abdominal
aortic aneurysm repair. Unfortunately, the critical care literature,
which has defined adrenal insufficiency, focuses mostly on septic
patients. In this subset the prevalence of occult adrenal insuffi-
ciency has been reported from 0.1% to 28%, which would make
widespread screening impractical, due to limited sensitivity of the
test. It may be more prudent to first look at these elective surgical
patients who develop adrenal insufficiency and identify factors thatpredispose them to this state. This would allow us to analyze
whether aortic surgery in and of itself is a predictor for adrenal
insufficiency and, more important, to define which patients would
benefit from testing.
The second question referred to how open versus endovas-
cular repair affected cortisol levels. A lot of our findings revealed
that patients with adrenal insufficiency presented with the con-
stellation of the systemic inflammatory response syndrome (SIRS) or
a preseptic type of state. In this setting, among other things, patients
tend to have a downregulation of their cortisol receptors, leading to a
state of functional hypoadrenalism. Theoretically, if patients undergo-
ing endograft repair manifest the same physiology, they should have
similar end points in terms of their adrenal function.
Dr Thomas Cogbill (LaCrosse, Wis). I think this is a very
important topic and one that is overlooked. It has been an area of
interest at our institution for many years.
In your paper you had one patient you said had true adrenal
insufficiency, and I assume that was a patient that you feel probably
had primary adrenal insufficiency. The other patients had what you
called hypoadrenalism, which probably was central or secondary
adrenal insufficiency. I wondered if you worked your patients up
JOURNAL OF VASCULAR SURGERY
May 2004950 Parikshak et alany further. Were you able to more accurately determine by CT
scans, ACTH levels, or other hormonal testing how many of your
patients had permanent primary adrenal insufficiency from bilateral
adrenal hemorrhage or from ischemia and how many had demon-
strated more transient secondary or central adrenal insufficiency?
Finally, how many of your patients required long-term or perma-
nent steroid replacement therapy?
Dr Parikshak. In our series the patient with true adrenal
dysfunction did not present with classical biochemical features or
adrenal insufficiency, and was not steroid-dependent prior to his
presentation. Could he have had some chronic adrenal failure? It is
possible, but we feel that probably the stress state unmasked a
hypofunctioning adrenal response in that patient.
Additionally, none of our patients were discharged on steroid
therapy, indicating that the adrenal failure was secondary in nature.
We did not work up our patients with CT scans or further hor-
monal testing. Unfortunately, for unclear reasons, our follow-up
was limited. We had about a 30% follow-up listed for our entirepopulation of ruptured aneurysm repairs, of which only one patient
in the adrenal insufficiency group returned. In this patient there
was no stigmata of adrenal insufficiency and no long-term need for
steroid replacement.
Dr Iraklis Pipinos (Omaha, Neb). I wonder if there are
patients with adrenal insufficiency in your series who had patho-
logic evaluation of their adrenals. For example, did you obtain an
autopsy of any of your patients who died, and what exactly were the
findings in the adrenals, if any?
Dr Parikshak. Unfortunately, we did not have any autopsy-
confirmed pathologic diagnoses of adrenal insufficiency. Some
reports have noted that patients diagnosed with adrenal insuffi-
ciency can have some coagulopathy, with some associated adrenal
hemorrhage, that may have induced adrenal failure. However,
these findings are not present in all patients, and the exact etiology
is not entirely clear. The key from our standpoint is that adrenal
insufficiency is usually an occult state that is manifested by a stress
situation.
